- ►annals.org TA Lee, AS Pickard, DH Au, B Bartle, KB … - Annals of Internal Medicine, 2008 - Am Coll Physicians Design: Nested case–control study in a cohort identified between 1 October
1999 and 30 September 2003 and followed through 30 September 2004 by using
National Veterans Affairs inpatient, outpatient, pharmacy, and mortality ... Cited by 34 - Related articles - All 8 versions
- ►utmem.edu [PDF] S Singh, YK Loke, CD Furberg - Jama, 2008 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. Cited by 68 - Related articles - All 12 versions
DP Tashkin, B Celli, S Senn, D Burkhart, S … - New England Journal of Medicine, 2008 - content.nejm.org Methods In this randomized, double-blind trial, we compared 4 years of therapy
with either tiotropium or placebo in patients with COPD who were permitted to
use all respiratory medications except inhaled anticholinergic drugs. The ... Cited by 136 - Related articles - All 8 versions
S Kesten, M Jara, C Wentworth, S Lanes - Chest, 2006 - chestjournal.chestpubs.org Methods: We conducted a pooled analysis of adverse event data from 19
randomized, double-blind, placebo-controlled trials with tiotropium in patients
with obstructive lung disease. We computed incidence rates and rate ratios ... Cited by 46 - Related articles - BL Direct - All 6 versions
C Macie, K Wooldrage, J Manfreda, N … - … Journal of Chronic Obstructive Pulmonary Disease, 2008 - pubmedcentral.nih.gov We used the Manitoba Health database to examine the relationship between use of
inhaled respiratory drugs in people with chronic obstructive respiratory
diseases and cardiovascular hospitalizations from 1996 through 2000. The ... Cited by 11 - Related articles - BL Direct - All 6 versions
Y Oba, T Zaza, DM Thameem - … Journal of Chronic Obstructive Pulmonary Disease, 2008 - pubmedcentral.nih.gov COPD is a chronic disease and, like many other chronic diseases, there is no
treatment to reverse the severity of the disease except for lung transplant. To
date, no inhaled medications have been shown to improve survival. ... Cited by 4 - Related articles - All 5 versions
J Moita, C Bárbara, J Cardoso, R Costa, M … - Pulmonary Pharmacology & Therapeutics, 2008 - Elsevier This study evaluated whether the effect of tiotropium on the change in trough
forced expiratory volume in 1 s (FEV 1 ), vs. placebo, is affected by smoking
status. In a 3-month, double-blind study in 31 centres in Portugal, 311 ... Cited by 7 - Related articles - All 2 versions
- ►bmj.com DD Sin, JV Tu - British Medical Journal, 2000 - thorax.bmj.com Obstructive airway disease is a progressive condition that causes a great deal
of morbidity and mortality. 1 Despite recent improvements in its management,
mortality rates from obstructive airway disease continue to rise. 2 There ... Cited by 29 - Related articles - BL Direct - All 7 versions
T Voshaar, R Lapidus, R Maleki-Yazdi, W … - Respiratory medicine, 2008 - Elsevier A total of 719 patients were randomized; the majority were male (69%) with a
mean pre-bronchodilator FEV 1 (% predicted) of 40.7%. The mean treatment
differences between tiotropium 5 and 10 μg and placebo for the primary ... Cited by 11 - Related articles - All 18 versions
T Ringbaek, K Viskum - Respiratory medicine, 2003 - Elsevier Background: To determine whether ipratropium was associated with premature death
in patients with asthma and chronic obstructive pulmonary disease (COPD).
Methods: A longitudinal cohort of 827 patients with COPD and 273 with ... Cited by 25 - Related articles - BL Direct - All 8 versions
